Aureobasidium pullulans place among human pathogens opportunistic infections (literature review)

Bagirova N.S.

doi:https://doi.org/10.17116/labs20187212-18

Bagirova N.S.

N.N. Blokhin Cancer Research Center, Laboratory of Microbiological Diagnosis and Treatment of Infections in Oncology, Moscow, Russia

Aureobasidium pullulans place among human pathogens opportunistic infections (literature review)

Authors:

Bagirova N.S.

More about the authors

Journal: Laboratory Service. 2018;7(2): 12‑18

DOI: 10.17116/labs20187212-18

Read: 4125 times

Download PDF (RU)

Contact the author

Table of contents

To cite this article:

Bagirova NS. Aureobasidium pullulans place among human pathogens opportunistic infections (literature review). Laboratory Service. 2018;7(2):12‑18. (In Russ.)
https://doi.org/10.17116/labs20187212-18

Подписка 2025 Лабораторная служба (Laboratory Service)

Использование инфографики авторами научных работ

Close metadata

Recommended articles:

From atopy to infection — a clinical case of combined skin pathology. Russian Journal of Clinical Dermatology and Venereology. 2025;(4):430-436

Abstract:

Aureobasidium pullulans is a saprophytic fungus that is widely distributed in the environment and is actively used in various industrial technologies. Like many saprophytic fungi, under certain conditions A. pullulans can cause opportunistic mycoses in humans. Deep mycosis caused by A. pullulans, often difficult to treat. Standard therapy is absent. The management of such patients is based on in vitro data in animal experiments, on the clinical experience obtained mainly in the expert evaluation of the described clinical cases.

Keywords:

Aureobasidium pullulans

dematiaceous fungi

black fungi

mycosis

phaeohyphomycosis

Authors:

Bagirova N.S.

N.N. Blokhin Cancer Research Center, Laboratory of Microbiological Diagnosis and Treatment of Infections in Oncology, Moscow, Russia

Close metadata

References:

Krishnan NS. Emerging fungal infections in cancer patients — a brief overview Med Mycol Open Access. 2016;2:16. https://doi.org/10.21767/2471-8521.100016
Singh R, Gaur R, Biswas P, Bansal S. Aureobasidium pullullans, an economically important black yeast. J Basic Applied Mycology. 2015;11:1-4.
Chan GF, Puad MS, Chin CF, Rashid NA Emergence of Aureobasidium pullulans as human fungal pathogen and molecular assay for future medical diagnosis. Folia Microbiol. (Praha). 2011;56(5):459-467. Epub 2011 Sep 10 https://doi.org/10.1007/s12223-011-0070-9
Dictionary of the Fungi 10th ed. Co-published by: commonwealth scientific and industrial research organisation. Eds. Kirk PM, Cannon PF, Stalpers JA, Minter DW. Wallingford, UK: CAB International. 2008;771.
Kul’ko AB. The spectrum of pathogens of deep human mycoses. Onkogematologiya. 2012(3):55-61. (In Russ.)
Revankar SG, Sutton DA. Melanized fungi in human disease. Clin Microbiol Rev. 2010 Oct;23(4):884-928. https://doi.org/10.1128/CMR.00019-10
Hussain N, Revankar SG. Black mold infections: what we know and what we need to know. Curr Clin Micro Rpt. 2017;4:106. https://doi.org/10.1007/s40588-017-0062-x
Lihachev AN. Location and concentration of the sources of propagules mikromitcetov indoors. Uspekhi medicinskoj mikologii. 2005;5(3):72-74. (In Russ.)
Hibbett DS, Binder M, Bischoff JF, Blackwell M, Cannon PE, Eriksson OE, Huhndorf S, James T, Kirk PM, Lucking R, Thorsten Lumbsch H, Lutzoni F, Matheny PB, McLaughlin DJ, Powell MJ, Redhead S, Schoch CL, Spatafora JW, Stalpers JA, Vilgalys R, Aime MC, Aptroot A, Bauer R, Begerow D, Benny GL, Castlebury LA, Crous PW, Dai YC, Gams W, Geiser DM, Griffith GW, Gueidan C, Hawksworth DL, Hestmark G, Hosaka K, Humber RA, Hyde KD, Ironside JE, Koljalg U, Kurtzman CP, Larsson KH, Lichtwardt R, Longcore J, Miadlikowska J, Miller A, Moncalvo JM, Mozley-Standridge A, Oberwinkler F, Parmasto E, Reeb V, Rogers JD, Roux C, Ryvarden L, Sampaio JP, Schussler A, Sugiyama J, Thorn RG, Tibell L, Untereiner WA, Walker C, Wang Z, Weir A, Weiss M, White MM, Winka K, Yao KJ, Zhang N. A higher-level phylogenetic classification of the fungi. Mycol Res. 2007;111:509-547.
De Hoog GS, Horre R. Molecular taxonomy of the Alternaria and Ulocladium species from humans and their identification in the routine laboratory. Mycoses. 2002;45:259-276.
Chowdhary JF, GuarroMJ, de Hoog GS, Kathuria S, Arendrup MC, Arikan-Akdagli C, Akova M, Boekhout T, Caira M, Guinea J, Chakrabarti A, Dannaoui E, van Diepeningen A, Freiberger T, Groll AH, Hope WW, Johnson E, Lackner M, Lagrou K, Lanternier F, Lass-Flörl C, Lortholary O, Meletiadis J, Muñoz P, Pagano L, Petrikkos G, Richardson MD, Roilides E, Skiada A, Tortorano AM, Ullmann AJ, Verweij PE, Cornely OA, Cuenca-Estrella M. ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clinical Microbiology and Infection. 2014 April;20(Suppl. 3). https://doi.org/10.1111/1469-0691.12515
Polak A. Melanin as a virulence factor in pathogenic fungi. Mycoses. 1989;33(5):215-223.
Soeria-Atmadja D, Annica Önell, Borga A. IgE sensitization to fungi mirrors fungal phylogenetic systematics. J Allergy Clin Immunol. 2010;125(6):1379-1386. https://doi.org/10.1016/j.jaci.2010.02.028
Temprano J, Becker BA, Hutcheson PS, Knutsen AP, Dixit A, Slavin RG. Hypersensitivity pneumonitis secondary to residential exposure to Aureobasidium pullulans in 2 siblings. Ann Allergy Asthma Immunol. 2007;99(6):562-566.
Engelhart S, Rietschel E, Exner M, Lange L. Childhood hypersensitivity pneumonitis associated with fungal contamination of indoor hydroponics. Int J Hyg Environ Health. 2009;212(1):18-20.
Wada Y, Kitajima H, Kubo M. A boy highly suspected of hypersensitivity pneumonitis characterized by generalized mucosal lesions. Nihon Rinsho Meneki Gakkai Kaishi (Japanese) 1996;19(5):524-536.
Kazemi A, Robson GD, Denning DW. Identification, isolation, cloning and sequencing apartialannexin gene from Aureobasidium pullulans. MJIRl. 2005;19(30):255-265.
Salkin IF, Martinez JA, Kemna ME. Opportunistic infection of the spleen caused by Aureobasidium pullulans. J Clin Microbiol. 1986;23(5):828-831.
Javad Najafzadeh M, Sutton DA, Saradeghi Keisari M, Zarrinfar H, Sybren de Hoog G, Anuradha Chowdhary, Meise JF. In vitro activities of eight antifungal drugs against 104 environmental and clinical isolates of Aureobasidium pullulans. Antimicrob Agents and Chemother. 2014 September;58(9):5629-5631. https://doi.org/10.1128/AAC.03095-14
Gevorkyan SA, Kurakov AV, Novikova ND, Goginyan VB. Distribution of opportunistic fungi in the microbiota of biodamage of polymers of space technology. Uspekhi meditsinskoi mikologii. 2005;5(3):58-60. (In Russ.)
Shadrivova OV, Frolova EV, Filippova LV, Uchevatkina AE, Volkova AG, Popova MO, Zubarovskaya LS, Zyuzgin IS, Ruzhinskaya OS, Hostelidi SN, Ignat’eva SM, Bogomolova TS, Chernopyatova RM, Vasil’eva NV, Afanas’ev BV, Klimko NN. Kliniko-immunologicheskaya harakteristika invazivnogo aspergilleza u gematologicheskih pacientov. Problemy medicinskoj mikologii. 2013;15(2):28-34 (In Russ.)
Zitvogel L, Apetoh L, Ghiringhelli F, Kroemer G. Immunological aspects of cancer chemotherapy. Immunol. 2008;8:59-73.
Motoyoshi Y, Kaminoda K, Saitoh O, et al. Different mechanisms for anti-tumor effects of low — and high-dose cyclophosphamide. Oncology Reports. 2006;16(1):141-146.
Segal BH. Role of macrophages in host defense against aspergillosis and strategies for immune augmentation. The Oncologist. 2007;12(2):7-13.
Stevens D.A. Th1/Th2 in aspergillosis. Med Mycology. 2006;44(1): 229-235.
Marfenina OE, Fomicheva GM, Kul’ko AB. Environmental conditions for the development of potentially pathogenic filamentous fungi. Uspekhi medicinskoj mikologii. 2005;5(3):74-77. (In Russ.)